Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ImClone's BLA filing for Erbitux not accepted by FDA

Jan. 2, 2002

ABX-EGF enters phase II trial for colorectal cancer

Jan. 2, 2002

Preliminary preclinical data demonstrate tumor vascular targeting efficacy of OXI-4503

Dec. 31, 2001

Novel epothilone derivatives from Schering act as microtubule-stabilizing agents

Dec. 31, 2001

Schering discloses new series of antiangiogenic agents

Dec. 31, 2001

AstraZeneca and Lilly to collaborate on clinical trials with ZD-1839 and gemcitabine combination

Dec. 28, 2001

Korean researchers identify new CDK inhibitors

Dec. 27, 2001

Myriad Genetics seeks clearance for new clinical trial of Flurizan

Dec. 27, 2001

New option for early-stage prostate cancer receives FDA clearance

Dec. 27, 2001

Thalomid granted orphan drug status in Europe for multiple myeloma and ENL

Dec. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...